Johnson & Johnson Applies For Emergency Use Approval Of Its Single-Dose COVID-19 Vaccine In India

J&J COVID-19 Vaccine India: "On August 5, 2021 Johnson & Johnson Pvt Ltd applied for EUA of its single-dose COVID-19 vaccine to the government of India," a Johnson & Johnson India spokesperson said in a statement.

Global healthcare major Johnson & Johnson today said it has applied for Emergency Use Authorisation (EUA) of its single-dose COVID-19 vaccine in India. On Monday, the company had said that it remained committed to bringing its single-dose COVID-19 vaccine to India and looks forward to ongoing discussions with the Indian government. "On August 5, 2021 Johnson & Johnson Pvt Ltd applied for EUA of its single-dose COVID-19 vaccine to the government of India," a Johnson & Johnson India spokesperson said in a statement. This is an important milestone that paves the way for bringing the company''s single-dose COVID-19 vaccine to the people of India, and the rest of the world, through a collaboration with Biological E Limited, the statement added.